This study elucidates the CEBPA-ACSL4-lipid catabolism pathway in TACE treatment, highlighting the mechanistic role of CEBPA-ACSL4 in inducing lipid catabolism and protecting HCC cells from glucose starvation-induced cell death. The gene discussed is ACSL4; the disease is hepatocellular carcinoma.